- China Res Microelec has reported a 1Q net income of 33.2 million yuan, falling short of the estimated 331.5 million yuan.
- The company’s 1Q revenue also missed estimates at 2.12 billion yuan, compared to the forecasted 2.64 billion yuan.
- The reported EPS (earnings per share) was at 2.51 RMB cents.
- Despite the misses, the company has received twelve ‘buy’ ratings, one ‘hold’ rating and two ‘sell’ ratings from analysts.
“`
A look at China Resources Microelectroni Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 5 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
China Resources Microelectronics Limited’s long-term outlook, as assessed by Smartkarma Smart Scores, paints a positive picture. With strong ratings in Growth, Resilience, and Momentum, the company seems poised for continued success in the electronic products and semiconductor manufacturing sector. A high Growth score implies the potential for expansion and development, while a top-notch Resilience rating suggests the company’s ability to weather economic uncertainties. Additionally, a strong Momentum score indicates positive market sentiment and performance.
Despite slightly lower scores in Value and Dividend, China Resources Microelectronics Limited’s overall outlook remains promising. The company’s focus on open foundries, integrated circuits, and high technology microelectronics aligns well with the industry’s future trends. These scores indicate a solid foundation for growth and innovation in the coming years, positioning the company as a key player in the electronic products market.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
